A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder

Journal of Clinical Psychiatry

Volumn 65, Issue 3, 2004, Pages 432-441

  Goodwin, Guy M ^a,g   Bowden, Charles L ^b   Calabrese, Joseph R ^c   Grunze, Heinz ^d   Kasper, Siegfried ^e   White, Robin ^f   Greene, Paul ^f   Leadbetter, Robert ^f  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF VIENNA   (Austria)

^f GLAXOSMITHKLINE   (United States)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; LITHIUM CARBONATE; TRANQUILIZER; TRIAZINE DERIVATIVE;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG ADMINISTRATION; DRUG TOLERANCE; FEMALE; HOSPITALIZATION; HUMAN; MALE; META ANALYSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; FEMALE; HUMANS; LITHIUM CARBONATE; MALE; PROSPECTIVE STUDIES; RECURRENCE; SEVERITY OF ILLNESS INDEX; TRIAZINES;

EID: 2342540409     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0321     Document Type: Article

References (32)

1. Regier D, Narrow W, Rae D. The de facto mental and addictive disorders service system: epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993;50:85-94 (Pubitemid 23059313)
2. Kessler R, McGonagle K, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:08-19 (Pubitemid 24028993)
3. Hirschfeld RMA, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003;64:53-59 (Pubitemid 36182230)
4. Judd L, Akiskal H, Schettler P, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002;59:530-537 (Pubitemid 34602935)
5. Kupka R, Nolen W, Altshuler L, et al. The Stanley Foundation Bipolar Network, 2: preliminary summary of demographics, course of illness and response to novel treatments. Br J Psychiatry 2001;178:S177-S183 (Pubitemid 32530347)
6. Kupfer DJ, Frank E, Grochocinski VJ, et al. Demographic and clinical characteristics of individuals in a bipolar disorder case registry [CME]. J Clin Psychiatry 2002;63:120-125 (Pubitemid 34173848)
7. Osby U, Brandt L, Correia N, et al. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001;58:844-850 (Pubitemid 32979302)
8. Dilsaver S, Chen Y-H, Swann A, et al. Suicidality in patients with pure and depressive mania. Am J Psychiatry 1994;151:1312-1315 (Pubitemid 24281755)
9. Simpson SG, Jamison KR. The risk of suicide in patients with bipolar disorders. J Clin Psychiatry 1999;60(suppl 2):53-56 (Pubitemid 29101963)
10. Schou M. The effect of prophylactic lithium treatment on mortality and suicidal behavior: a review for clinicians. J Affect Disord 1998;50:253-259 (Pubitemid 28551794)
11. Bauwens F, Tracy A, Pardoen D, et al. Social adjustment of remitted bipolar and unipolar out-patients. Br J Psychiatry 1991;159:239-244
12. Coryell W, Scheftner W, Keller M, et al. The enduring psychosocial consequences of mania and depression. Am J Psychiatry 1993;150:720-727 (Pubitemid 23137676)
13. Serretti A, Cavallini M, Macciardi F, et al. Social adjustment and selfesteem in remitted patients with mood disorders. Eur Psychiatry 1999;14:137-142 (Pubitemid 36187794)
14. MacQueen G, Young L, Joffe R. A review of psychosocial outcome in patients with bipolar disorder. Acta Psychiatr Scand 2001;103:163-170 (Pubitemid 32154347)
15. Hirschfeld RMA, Bowden C, Gitlin M, et al. Practice Guideline for the Treatment of Patients With Bipolar Disorder [Revision]. Am J Psychiatry 2002;159(suppl 4):1-50 (Pubitemid 34274969)
16. Calabrese JR, Bowden CL, Sachs GS. A double-blind, placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999;60:79-88 (Pubitemid 29104383)
17. Frye M, Ketter T, Kimbrell T, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000;20:607-614 (Pubitemid 30953799)
18. Obrocea G, Dunn R, Frye M, et al. Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biol Psychiatry 2002;5:253-260 (Pubitemid 34142637)
19. Calabrese JR, Fatemi S, Woyshville M. Antidepressant effect of lamotrigine in rapid cycling bipolar disorder [letter]. Am J Psychiatry 1996;153:1236 (Pubitemid 26299855)
20. Calabrese JR, Bowden C, McElroy S. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. Am J Psychiatry 1999;156:1019-1023 (Pubitemid 29302793)
21. Calabrese JR, Suppes T, Bowden CL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 2000;61:841-850 (Pubitemid 30947798)
22. Burgess S, Geddes J, Hawton K, et al. Lithium for maintenance treatment of mood disorder (Cochrane Review). Cochrane Database Syst Rev 2001; 2:CD003013
23. Denicoff K, Smith-Jackson E, Disney E, et al. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997;58:470-478 (Pubitemid 27527442)
24. Lambert PA, Venaud G. Comparative study of valpromide versus lithium in the treatment of affective disorders. Nervure 1992;5:57-65
25. Hopkins HS, Gelenberg AJ. Serum lithium levels and the outcome of maintenance therapy of bipolar disorder. Bipolar Disord 2000;2:174-179
26. Bowden C, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar 1 disorder. Arch Gen Psychiatry 2003;60:392-400 (Pubitemid 36403000)
27. Calabrese JR, Bowden CL, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64:1013-1024 (Pubitemid 37158246)
28. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978;35:837-844 (Pubitemid 9076798)
29. Prien R, Caffey E, Klett J. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Arch Gen Psychiatry 1973;28:337-341
30. Prien R, Klett J, Caffey E. Lithium carbonate and imipramine in prevention of affective episodes. Arch Gen Psychiatry 1973;29:420-425
31. Perlis R, Sachs G, Lafer B, et al. Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry 2002;159:1155-1159 (Pubitemid 34743255)
32. Bowden C, Calabrese JR, McElroy S, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000;57:481-489 (Pubitemid 30257262)